3 weeks. $35K. Senior-led.

Find exactly where your growth stops becoming enterprise value.

The Enterprise Value Gap Diagnostic is the structured first step into every engagement. In three weeks, it locates the gap capping your valuation and scopes the Sprint that closes it. Most companies find that gap in the diligence room. This finds it first.

WHY DIAGNOSE BEFORE YOU BUILD

A fix aimed at the wrong problem is an expensive way to stay stuck.

Growth problems and value problems look identical from the inside. A slowing pipeline, a stretching sales cycle, a founder who has quietly become the bottleneck. Each one feels urgent. Each one points to a different gap that needs a different fix.

Choose the Sprint before you have found the gap, and you spend 90 days and six figures solving the wrong problem. The gap stays open, and you usually learn which gap it really was in the diligence room, where it comes straight out of the multiple.

No surgeon operates before the scan. The Diagnostic is the scan.

01

Value Gap

Whether your growth is the kind buyers pay for, or the kind that thins out in diligence.

Auto-advances through the stages. Tap any point to take control.

These six stages are the Enterprise Value Creation System, the framework behind every Legacy DNA engagement. Explore the EVCS →

What you walk away with

Two deliverables. Both are decisions you can act on, not reports that sit in a drawer.

Deliverable 01

The Gap Report

Which stage is breaking and why, with changes ranked by what moves enterprise value most. You leave knowing the one gap to close first and what it costs to wait.

Deliverable 02

The Scoped Sprint Plan

Which of the five Sprints comes first, what it builds, and in what order. The next 90 days are decided before they start.

Who it's for

Built for PE-backed, founder-led, or growth-stage pharmacy and healthtech companies, $10M+ in revenue. It is the right first step when:

01Your board is asking sharper questions than your current story answers.
02Growth is real, and it is not showing up in how the business gets valued.
03An exit window is opening in the next 12 to 36 months.
04Performance looks strong, and you cannot yet prove why in terms a buyer trusts.
05A transaction is coming, and the growth story is still scattered across the team.

BioPlus found it first.

Before any building, the work started where every engagement starts: finding where growth was real but not converting into enterprise value, then sequencing the fixes in the right order.

$750M → $2B

in revenue

13 quarters

of consecutive growth

+202%

gross profit growth

2 exits

Nautic Partners to Elevance Health

Ready to close the gaps? Start with a Strategic Fit Call.

The Strategic Fit Call is a complimentary 45 minute session with Dr. Roxie Mooney. It’s an honest read of where you stand and the right next step.